Indegene acquires Trilogy Writing & Consulting GmbH
India, March 28 -- Bengaluru-based Indegene has announced the acquisition of Trilogy Writing & Consulting GmbH, a global provider of specialty medical writing capabilities across clinical, regulatory, safety and medical content to life sciences companies. The acquisition by Indegene Ireland, a subsidiary of Indegene Limited, augments Indegene's depth of clinical and regulatory writing expertise for market authorisation applications globally.
Trilogy Writing & Consulting is a Germany, UK, and US-based, medical writing consultancy with know-how in the development and delivery of clinical, regulatory, safety, and medical content. It applies its expertise and unique approaches to deliver quality medical writing output.
According toGrand Vie...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.